ATH 11.1% 0.5¢ alterity therapeutics limited

phase 2b/3 funding., page-6

  1. 322 Posts.
    Guys,
    I believe that Southern Cross Equities report mentioned $20 million as the cost of the Phase2b. If this is a success they would have no trouble raising the funds for P3.

    http://www.pranabio.com/downloads/analyst_reviews/SCE%20Report%2030%20Sept%202009.pdf

    Regards PJ
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $26.60M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $1.288K 257.5K

Buyers (Bids)

No. Vol. Price($)
103 97718686 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179254 15
View Market Depth
Last trade - 09.59am 26/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.